SCHEMBL1498442

SCHEMBL1498442

CC(C)(C)N(C(=O)O)[C@H]1CC[C@@H](CS(=O)(=O)c2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CACNA1B Q00975 4/20 0.49
▸ POLB P06746 1/20 0.46
▸ CYP3A4 P08684 3/20 0.44
▸ CYP2C19 P33261 3/20 0.44
▸ JAK2 O60674 1/20 0.44
▸ TYK2 P29597 1/20 0.44
▸ JAK3 P52333 1/20 0.44
▸ CYP2C9 P11712 2/20 0.43
▸ CYP2D6 P10635 2/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ CCR2 P41597 8/20 0.43
▸ HDAC3 O15379 1/20 0.42
▸ HDAC11 Q96DB2 1/20 0.42
▸ HDAC8 Q9BY41 1/20 0.42
▸ HDAC6 Q9UBN7 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ NR1I2 O75469 1/20 0.42
▸ KCNH2 Q12809 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1498439 1.00 CACNA1B (0.49) CACNA1BPOLBCYP3A4CYP2C19JAK2
SCHEMBL1498596 0.90 JAK2 (0.51) CACNA1BPOLBCYP3A4CYP2C19JAK2
SCHEMBL1498597 0.90 JAK2 (0.51) CACNA1BPOLBCYP3A4CYP2C19JAK2
SCHEMBL1498296 0.83 ELOVL6 (0.44) CACNA1BPOLBCYP3A4NPSR1NR1I2
SCHEMBL12542382 0.80 CCR2 (0.47) CACNA1BCYP3A4CYP2C19JAK2TYK2
SCHEMBL12692995 0.80 CCR2 (0.47) CACNA1BCYP3A4CYP2C19JAK2TYK2
SCHEMBL12542386 0.80 CCR2 (0.47) CACNA1BCYP3A4CYP2C19JAK2TYK2
SCHEMBL10476054 0.80 CCR2 (0.52) CACNA1BPOLBCCR2NPSR1
SCHEMBL10476062 0.80 CCR2 (0.52) CACNA1BPOLBCCR2NPSR1
SCHEMBL10476055 0.80 CCR2 (0.52) CACNA1BPOLBCCR2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011035159-A1 ARYL SULPHONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS ZALICUS PHARMACEUTICALS LTD. (CA) 2011-03-24 — — WO disclosed
Send feedback